Related Experiment Video
Updated: Aug 6, 2026

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
Published on: May 30, 2025
Implementation factors shaping British Columbia's drug decriminalization pilot: A systematic review with narrative
Farihah Ali1, Shannon Chellew Paternostro2, Sameer Imtiaz3
1Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), 250 College St., 9th floor, Toronto, ON, M5T 1R8, Canada; Ontario Node, Canadian Research Initiative in Substance Matters (CRISM), 250 College St., 9th floor, Toronto, ON, M5T 1R8, Canada; Dalla Lana School of Public Health, University of Toronto, 155 College St., Toronto, ON, M5T 3M7, Canada; Faculty of Applied Health and Community Studies, School of Applied Health, Clinical Research, Sheridan College, 7899 McLaughlin Rd., Brampton, ON, L6Y 5H9, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), 1001 Queen St. West, Toronto, ON, M6J 1H4, Canada.
Background:
In January 2023, British Columbia (BC) became the first Canadian province to implement a legally sanctioned drug decriminalization policy, removing criminal penalties for adults possessing 2.5 g or less of opioids, cocaine, methamphetamine, and MDMA. Introduced as a three-year pilot, it aimed to reframe substance use as a public health issue, reduce stigma, and improve health and social service engagement. Criminal penalties were reintroduced for drug possession in most public spaces in May 2024, and the pilot ended in January 2026. Its termination has been interpreted as policy failure; this review aimed to examine how the pilot was implemented in practice and to identify factors that shaped its operationalization and early implementation-relevant outcomes.
Methods:
We conducted a systematic review with narrative synthesis of peer-reviewed literature examining implementation-relevant aspects of BC's decriminalization pilot. Six databases were searched (January-February 2026) for studies published May 31, 2022-February 1, 2026. The protocol was registered in PROSPERO (CRD420251271694).
Results:
Twenty-seven studies were included. Four cross-cutting implementation barriers were identified: pilot design features, public and cross-sector communication gaps, limited frontline training, and insufficient funding and infrastructure. Design features included the 2.5 g possession threshold, misalignment with real-world drug use patterns; the three-year timeframe, which constrained system-level effects; and the May 2024 amendment, which introduced additional instability. The pilot was implemented without commensurate investment in harm reduction, treatment, or housing infrastructure, within already constrained systems.
Conclusion:
BC's decriminalization pilot suggests the effects of legal reform are shaped by implementation context. Early outcomes may reflect design features, institutional readiness, and system capacity rather than legal change alone; longer-term impacts remain uncertain. Future reforms should align legal change with coordinated implementation, operational guidance, public communication, and adequate service infrastructure.
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
Factors Affecting Drug Response: Overview
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Regulation